Daily news email for August 06, 2012 | Click here for updated news
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)
NIH Translational Center Should Raise All Boats, BIO Says
Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update
Biotechnology to be 21st-century industry: Life Tech CEO
|
Burrill Report
Bioethics Commission Readies Privacy Advice
Customized Therapy
Biorenewables Companies Make Headway
Globus Medical Prices IPO at $12 per Share
Bristol-Myers Bet on Hepatitis C Drug Takes Major Hit
|
CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend
New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising
Technology companies adapt interactive video concepts for clinical trial informed consent
CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases
New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
|
New York Times- Pharmaceuticals
Novartis and Penn Unite On Anticancer Approach
China Arrests 2,000 in Counterfeit Drug Crackdown
2,000 Arrested in China in Crackdown on Counterfeit Drugs
Bristol-Myers to Suspend Hepatitis C Drug Study
A Focus on AIDS, Past and Present
|
OnBioVC
Stemgent, Inc.: Series C $6.3M
Genalyte, Inc.: Series A $11.8M
Relievant Medsystems, Inc.: Series D $30M
ImaginAb, Inc.: Series A $12.5M
BiO2 Medical, Inc.: Series B $13.7M
|
Outsourcing-Pharma
Wockhardt targets CMO space for diversification
Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles
Home visits = regulatory thumbs up ResearchNurses.co thinks so
Home visits are the key to patient retention, says ResearchNurses.co
Kemwell and Boehringer set to finish biologics plant in India
|
Sports News - ESPN
PSU practice opens with core players returning
Recruit decommits from PSU, off to Notre Dame
TCU QB Pachall won't face discipline from team
Former Trojans lineman Matua dies at age 28
Source: PSU's Brown will transfer to Oklahoma
|
Xconomy Life Sciences
U.S. Biotech Clusters Are Losing Their Anchor Tenants, and It Hurts
Life Sciences Roundup: Halozyme, Avalon Ventures, Auspex & More
Xconomist of the Week: John Reed on Sanford-Burnham's Drug Pipeline
Aveo, Mersana, Haemonetics, & More from the Boston Life Sciences Roundup
Aveo Shares Fall as FDA Questions Cancer Drug Survival Trend
|
Yahoo Biotech News
Slow, costly process stymies generic biotech drugs
(Reuters)
Analysis: Slow, costly process stymies generic biotech drugs
(Reuters)
Waves Break Coral Embryo into Identical Twins
(LiveScience.com)
Autoinjector Version of MS Drug Approved
(HealthDay)
Fake Avastin had salt, starch, chemicals: Roche
(Reuters)
|
